BioNJ revealed more details for its 13th Annual BioPartnering Conference, which returns in person after three years April 18 at The Palace at Somerset Park.
The event brings together stakeholders throughout the life sciences sector with a robust schedule that BioNJ says is designed to foster productive partnerships, create meaningful opportunities, grow the life sciences ecosystem, and bolster medical innovation.
“We’re thrilled to partner with once again with J.P. Morgan and Johnson & Johnson Innovation on BioNJ’s BioPartnering Conference, and are ecstatic to have Morgan Lewis join this elite group of Conference Partners for 2023,” said Debbie Hart, president and CEO, BioNJ, in a March 7 press release. “These organizations are dedicated to strengthening the ecosystem and supporting the life sciences industry in bringing new therapies and medicines to patients.”
The conference will offer networking opportunities, one-on-one partnering, a record number of company and startup pitches, exhibits and plenary sessions, with an impressive roster of industry thought leaders.
Additional features will include:
- A special session showcasing the winners from BioNJ’s Inaugural Health Equity in Clinical Trials MBA Case Competition;
- The opportunity to meet and hear from representatives from world-renowned institutions;
- And an Industry Showcase to learn about valuable resources, products and services available to companies in the BioNJ community.
“With a robust full-day agenda – including a highly anticipated networking reception offering the perfect opportunity to connect with future partners and investors – this year’s conference is on track to be bigger than ever,” Hart added. “Last year’s program convened over 500 attendees from 18 states as well as the District of Columbia, 11 countries, and more than 100 investors looking for new opportunities in which to invest.”
Full event details can be found here.